Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Study of Abituzumab in Combination With Cetuximab and FOLFIRI in Patients With Metastatic Colorectal Cancer.
- Status
- WITHDRAWN
- Phase
- PHASE2
FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM
- Status
- TERMINATED
- Phase
- PHASE3
Dabrafenib + Trametinib + PDR001 In Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Trifluridin/tipirACil in MeTastatIc Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE1
Immunophenotyping of Metastases From Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options
- Status
- COMPLETED
- Phase
- NA
FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation
- Status
- COMPLETED
- Phase
- PHASE2
Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).
- Status
- COMPLETED
- Phase
- PHASE4
Sym004 Versus Futuximab or Modotuximab in Patients With mCRC
- Status
- TERMINATED
- Phase
- PHASE2
A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC
- Status
- TERMINATED
- Phase
- PHASE2
EGFR-IL12-CART Cells for Patients With Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRC
- Status
- COMPLETED
- Phase
- PHASE2
Rechallenge of Prior Regimen in Third or Later-line Chemotherapy in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Durvalumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2